Developing new contraceptive methods for women, especially those who are obese.
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM – CORE FUNCTION ACTIVITIES FOR SITES OF FEMALE CONTRACEPTIVE STUDIES - UCSF
This study is looking for ways to create safer birth control options that help prevent unintended pregnancies while also reducing the risk of blood clots, especially for women who are overweight, and by joining in, you can help make these new methods better for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11166254 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive methods that not only prevent unintended pregnancies but also minimize the risk of venous thromboembolism (VTE), particularly in obese women. The Contraceptive Clinical Trials Network (CCTN) is dedicated to developing protocols and conducting clinical trials aimed at advancing contraceptive product development. By participating in this research, patients may contribute to the creation of safer and more effective contraceptive options tailored to their needs.
Who could benefit from this research
Good fit: Ideal candidates for this research include women seeking effective contraception, particularly those who are obese or have medical conditions that make current contraceptive options unsuitable.
Not a fit: Patients who are not seeking contraception or who do not have any health conditions that affect contraceptive use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer contraceptive methods that are effective for women with varying health conditions.
How similar studies have performed: Previous research has shown promise in developing new contraceptive methods, indicating that this approach could lead to significant advancements in women's reproductive health.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Kerns, Jennifer — University of California, San Francisco
- Study coordinator: Kerns, Jennifer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.